237 related articles for article (PubMed ID: 8407553)
1. Genetic changes and histopathological grades in human hepatocellular carcinomas.
Konishi M; Kikuchi-Yanoshita R; Tanaka K; Sato C; Tsuruta K; Maeda Y; Koike M; Tanaka S; Nakamura Y; Hattori N
Jpn J Cancer Res; 1993 Aug; 84(8):893-9. PubMed ID: 8407553
[TBL] [Abstract][Full Text] [Related]
2. Loss of heterozygosity and analysis of mutation of p53 in hepatocellular carcinoma.
Yumoto Y; Hanafusa T; Hada H; Morita T; Ooguchi S; Shinji N; Mitani T; Hamaya K; Koide N; Tsuji T
J Gastroenterol Hepatol; 1995; 10(2):179-85. PubMed ID: 7540433
[TBL] [Abstract][Full Text] [Related]
3. Genetic alterations in hepatocellular carcinomas: association between loss of chromosome 4q and p53 gene mutations.
Rashid A; Wang JS; Qian GS; Lu BX; Hamilton SR; Groopman JD
Br J Cancer; 1999 Apr; 80(1-2):59-66. PubMed ID: 10389978
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive allelotype study of hepatocellular carcinoma: potential differences in pathways to hepatocellular carcinoma between hepatitis B virus-positive and -negative tumors.
Okabe H; Ikai I; Matsuo K; Satoh S; Momoi H; Kamikawa T; Katsura N; Nishitai R; Takeyama O; Fukumoto M; Yamaoka Y
Hepatology; 2000 May; 31(5):1073-9. PubMed ID: 10796882
[TBL] [Abstract][Full Text] [Related]
5. Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.
Zondervan PE; Wink J; Alers JC; IJzermans JN; Schalm SW; de Man RA; van Dekken H
J Pathol; 2000 Oct; 192(2):207-15. PubMed ID: 11004697
[TBL] [Abstract][Full Text] [Related]
6. Deletion of chromosomes 9p and 17 associated with abnormal expression of p53, p16/MTS1 and p15/MTS2 gene protein in hepatocellular carcinomas.
Shao J; Li Y; Li H; Wu Q; Hou J; Liew C
Chin Med J (Engl); 2000 Sep; 113(9):817-22. PubMed ID: 11776078
[TBL] [Abstract][Full Text] [Related]
7. Tumor-suppressor p53 gene in hepatitis C and B virus-associated human hepatocellular carcinoma.
Shieh YS; Nguyen C; Vocal MV; Chu HW
Int J Cancer; 1993 Jun; 54(4):558-62. PubMed ID: 8390407
[TBL] [Abstract][Full Text] [Related]
8. p53 gene mutation spectrum in hepatocellular carcinoma.
Oda T; Tsuda H; Scarpa A; Sakamoto M; Hirohashi S
Cancer Res; 1992 Nov; 52(22):6358-64. PubMed ID: 1330291
[TBL] [Abstract][Full Text] [Related]
9. Genetic aberrations detected by comparative genomic hybridization in hepatocellular carcinomas: their relationship to clinicopathological features.
Kusano N; Shiraishi K; Kubo K; Oga A; Okita K; Sasaki K
Hepatology; 1999 Jun; 29(6):1858-62. PubMed ID: 10347130
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide analyses on loss of heterozygosity in hepatocellular carcinoma in Southern China.
Li SP; Wang HY; Li JQ; Zhang CQ; Feng QS; Huang P; Yu XJ; Huang LX; Liang QW; Zeng YX
J Hepatol; 2001 Jun; 34(6):840-9. PubMed ID: 11451167
[TBL] [Abstract][Full Text] [Related]
11. Mutations in TP53, CTNNB1 and PIK3CA genes in hepatocellular carcinoma associated with hepatitis B and hepatitis C virus infections.
Tornesello ML; Buonaguro L; Tatangelo F; Botti G; Izzo F; Buonaguro FM
Genomics; 2013 Aug; 102(2):74-83. PubMed ID: 23583669
[TBL] [Abstract][Full Text] [Related]
12. Accumulation of genetic changes during development and progression of hepatocellular carcinoma: loss of heterozygosity of chromosome arm 1p occurs at an early stage of hepatocarcinogenesis.
Kuroki T; Fujiwara Y; Tsuchiya E; Nakamori S; Imaoka S; Kanematsu T; Nakamura Y
Genes Chromosomes Cancer; 1995 Jul; 13(3):163-7. PubMed ID: 7669735
[TBL] [Abstract][Full Text] [Related]
13. p16 promoter hypermethylation in human hepatocellular carcinoma with or without hepatitis virus infection.
Narimatsu T; Tamori A; Koh N; Kubo S; Hirohashi K; Yano Y; Arakawa T; Otani S; Nishiguchi S
Intervirology; 2004; 47(1):26-31. PubMed ID: 15044833
[TBL] [Abstract][Full Text] [Related]
14. Alterations of tumor suppressor genes and allelic losses in human hepatocellular carcinomas in China.
Fujimoto Y; Hampton LL; Wirth PJ; Wang NJ; Xie JP; Thorgeirsson SS
Cancer Res; 1994 Jan; 54(1):281-5. PubMed ID: 7903205
[TBL] [Abstract][Full Text] [Related]
15. Allelotype analysis of hepatocellular carcinoma.
Piao Z; Park C; Park JH; Kim H
Int J Cancer; 1998 Jan; 75(1):29-33. PubMed ID: 9426686
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological significance of loss of heterozygosity and microsatellite instability in hepatocellular carcinoma in China.
Zhang SH; Cong WM; Xian ZH; Wu MC
World J Gastroenterol; 2005 May; 11(20):3034-9. PubMed ID: 15918185
[TBL] [Abstract][Full Text] [Related]
17. Expression of cyclin D1, cyclin E, cdk4 and loss of heterozygosity of 8p, 13q, 17p in hepatocellular carcinoma: comparison study of childhood and adult hepatocellular carcinoma.
Kim H; Lee MJ; Kim MR; Chung IP; Kim YM; Lee JY; Jang JJ
Liver; 2000 Apr; 20(2):173-8. PubMed ID: 10847487
[TBL] [Abstract][Full Text] [Related]
18. Analysis of DNA copy number aberrations in hepatitis C virus-associated hepatocellular carcinomas by conventional CGH and array CGH.
Hashimoto K; Mori N; Tamesa T; Okada T; Kawauchi S; Oga A; Furuya T; Tangoku A; Oka M; Sasaki K
Mod Pathol; 2004 Jun; 17(6):617-22. PubMed ID: 15133472
[TBL] [Abstract][Full Text] [Related]
19. Chromosome alterations in human hepatocellular carcinomas correlate with aetiology and histological grade--results of an explorative CGH meta-analysis.
Moinzadeh P; Breuhahn K; Stützer H; Schirmacher P
Br J Cancer; 2005 Mar; 92(5):935-41. PubMed ID: 15756261
[TBL] [Abstract][Full Text] [Related]
20. Accumulation of allelic loss on arms of chromosomes 13q, 16q and 17p in the advanced stages of human hepatocellular carcinoma.
Nishida N; Fukuda Y; Kokuryu H; Sadamoto T; Isowa G; Honda K; Yamaoka Y; Ikenaga M; Imura H; Ishizaki K
Int J Cancer; 1992 Jul; 51(6):862-8. PubMed ID: 1322376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
